Mercado mundial de la psoriasis: tendencias de la industria y pronóstico hasta 2029

Análisis y tamaño del mercado

En los últimos años, se prevé que el mercado de la psoriasis prolifere durante el período de pronóstico. A pesar de que la atención médica está migrando progresivamente hacia una atención basada en el valor para obtener mejores resultados para los pacientes y una mejor calidad de vida, el aumento global de la prevalencia de la psoriasis está fomentando las inversiones en estrategias de tratamiento y manejo. Como resultado, los fabricantes de la industria de la psoriasis han cambiado su enfoque hacia la investigación y el desarrollo para mejorar el manejo de la enfermedad, lo que ha dado como resultado la creación de medicamentos más nuevos y más efectivos.

Data Bridge Market Research analiza que el mercado de la psoriasis se valoró en USD 24,33 mil millones en 2021 y se espera que alcance los USD 49,20 mil millones para 2029, registrando una CAGR del 9,20% durante el período de pronóstico de 2022 a 2029. El informe de mercado curado por el equipo de Data Bridge Market Research incluye un análisis experto en profundidad, epidemiología del paciente, análisis de la cartera, análisis de precios y marco regulatorio.

Definición de mercado

La psoriasis es una enfermedad de la piel en la que las células cutáneas se reproducen diez veces más rápido de lo que deberían, lo que provoca la formación de manchas rojas y ásperas con escamas blancas en la piel. Pueden crecer en el cuero cabelludo, los codos, las rodillas y la zona lumbar, pero son más comunes en esas zonas. Es imposible transmitir la psoriasis de una persona a otra. La psoriasis aparece por primera vez en la edad adulta temprana. En la mayoría de las personas, solo afecta a unas pocas zonas. La psoriasis puede propagarse por todo el cuerpo en situaciones extremas.

Alcance del informe y segmentación del mercado

Psoriasis Market Dynamics

Drivers

• Rise in the prevalence of psoriasis

The rising prevalence of psoriasis is a major factor driving the psoriasis market's growth rate. Although the actual cause of psoriasis is unknown, some genetic and environmental factors may contribute to the disease's onset. The majority of current therapies try to slow disease progression by preventing keratinocyte hyperproliferation.  

• Increasing investment for healthcare infrastructure

Another significant factor influencing the growth rate of psoriasis market is the rising healthcare expenditure which helps in improving its infrastructure.

Furthermore, rising initiatives by public and private organizations to spread awareness about the will expand the psoriasis market. Additionally, high disposable income and changing lifestyle of people will result in the expansion of psoriasis market. Along with this, rising geriatric population and surge in biological therapy approval will enhance the market's growth rate.

Opportunities

• Increase in the number of research and development activities       

Moreover, the market's growth is fueled by an increase in the number of research and development activities. This will provide beneficial opportunities for the psoriasis market growth. The rising number of psoriasis cases worldwide has prompted manufacturing companies to embark on research and development initiatives to develop new psoriasis treatment alternatives.

Moreover, rising investment for the development of advanced technologies and an increase in the number of emerging markets will provide beneficial opportunities for the psoriasis market growth during the forecast period.

Restraints/Challenges

On the other hand, the high cost of the medication will obstruct the market's growth rate. The lack of healthcare infrastructure in developing economies and low awareness about psoriasis  and its associated complications will pose major challenges to the market's growth rate. Additionally, the dearth of favourable reimbursement policies will act as restrain and further impede the growth rate of market during the forecast period of 2022-2029.

This psoriasis market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the psoriasis market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Patient Epidemiology Analysis

Psoriasis is becoming more common all over the world. According to the World Psoriasis Day consortium, 125 million individuals suffer from psoriasis each year, accounting for 2 to 3% of the global population.

Psoriasis market also provides you with detailed market analysis for patient analysis, prognosis and cures. Prevalence, incidence, mortality, adherence rates are some of the data variables that are available in the report. Direct or indirect impact analyses of epidemiology to market growth are analysed to create a more robust and cohort multivariate statistical model for forecasting the market in the growth period.

COVID-19 Impact on Psoriasis Market

Since its emergence in December 2019, the COVID-19 virus has spread to nearly every country on the planet, prompting the World Health Organization (WHO) to declare it a public health emergency. Due to the financial crisis and the delay in specialty healthcare delivery while prioritizing COVID-19-related treatments, healthcare systems worldwide have been severely disrupted in the aftermath of the coronavirus pandemic. Patients were unable to see their controls for a variety of reasons, including difficulty accessing a doctor, fear of infection transmission, inability to continue therapies and essential procedures due to pandemic restrictions. Such considerations may have a negative impact on the market of psoriasis in recent months.

Recent Development

• In January 2022, The US Food and Drug Administration (FDA) had approved AbbVie's SKYRIZI (risankizumab-rzaa) for the treatment of individuals with active psoriatic arthritis (PsA). This systemic inflammatory disease affects the skin and joints and affects around 30% of psoriasis patients.

Global Psoriasis Market Scope

The psoriasis market is segmented on the basis of types, treatment, diagnosis, route of administration, end-users and distribution channel. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Types

• Nail Psoriasis
• Guttate Psoriasis
• Psoriatic Arthritis
• Others

Treatment

• Medication

Tumour necrosis factor inhibitors

Interleukin-inhibitors

Vitamin D analogues

Corticosteroids

Others

• Phototherapy
• Others

Diagnosis

• Physical Examination
• Skin Biopsy
• Others

Route of Administration

• Oral
• Topical
• Others

End-Users

• Hospitals
• Specialty Clinics
• Homecare
• Others

Distribution Channel

• Hospital Pharmacy
• Retail Pharmacy
• Online Pharmacy
• Others

Psoriasis Market Regional Analysis/Insights

The psoriasis market is analysed and market size insights and trends are provided by country, types, treatment, diagnosis, route of administration, end-users and distribution channel as referenced above.

The countries covered in the psoriasis market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America

North America dominates the psoriasis market because of the growing presence of major key players and the rising number of research and development activities will further propel the market's growth rate in this region.

Asia-Pacific are expected to grow during the forecast period due to the surging number of generic manufacturers and growing government initiatives in this region. Also, the development of healthcare infrastructure will further propel the market's growth rate in this region.

La sección de países del informe también proporciona factores de impacto de mercado individuales y cambios en la regulación en el mercado a nivel nacional que afectan las tendencias actuales y futuras del mercado. Puntos de datos como análisis de la cadena de valor aguas abajo y aguas arriba, tendencias técnicas y análisis de las cinco fuerzas de Porter, estudios de casos son algunos de los indicadores utilizados para pronosticar el escenario del mercado para países individuales. Además, la presencia y disponibilidad de marcas globales y sus desafíos enfrentados debido a la competencia grande o escasa de las marcas locales y nacionales, el impacto de los aranceles nacionales y las rutas comerciales se consideran al proporcionar un análisis de pronóstico de los datos del país.   

Análisis del panorama competitivo y de la cuota de mercado de la psoriasis

El panorama competitivo del mercado de la psoriasis proporciona detalles por competidor. Los detalles incluidos son una descripción general de la empresa, las finanzas de la empresa, los ingresos generados, el potencial de mercado, la inversión en investigación y desarrollo, las nuevas iniciativas de mercado, la presencia global, los sitios e instalaciones de producción, las capacidades de producción, las fortalezas y debilidades de la empresa, el lanzamiento de productos, la amplitud y la variedad de productos, el dominio de las aplicaciones. Los puntos de datos anteriores proporcionados solo están relacionados con el enfoque de las empresas en relación con el mercado de la psoriasis.

Algunos de los principales actores que operan en el mercado de la psoriasis son:

• Pfizer Inc. (Estados Unidos)
• GlaxoSmithKline plc (Reino Unido)
• Novartis AG (Suiza)
• Mylan NV (Estados Unidos)
• Industrias farmacéuticas Teva Ltd. (Israel)
• Sanofi (Francia)
• Boehringer Ingelheim International GmbH (Alemania)
• AstraZeneca (Reino Unido)
• Johnson & Johnson Private Limited (Estados Unidos)
• Bayer AG (Alemania)
• Merck & Co., Inc. (Estados Unidos)
• F. Hoffmann-La Roche Ltd. (Suiza)
• Compañía Bristol-Myers Squibb (Estados Unidos)
• Productos farmacéuticos Cadila (India) 
• Eli Lilly and Company (Estados Unidos)
• LEO Pharma A/S (Dinamarca)
• Cipla Inc. (Estados Unidos)
• Aurobindo Pharma (India)
• Lupino (India)
• Corporación Sumitomo (Japón)

SKU-53466